Avid CEO confident in Alzheimer's imaging agent Sat,16 Jul 2011 11:53 AM PDT Reuters - PARIS (Reuters) - The chief executive of Eli Lilly and Co's Alzheimer's imaging unit is confident it can create a training program for its imaging drug that will satisfy concerns raised by U.S. regulators. Full Story | |
U.S. pediatrician feels heat over child obesity idea Fri,15 Jul 2011 03:00 PM PDT Reuters - BOSTON (Reuters) - Boston pediatrician David Ludwig, the center of a media firestorm this week, wants to set the record straight on his view that a state should intervene in the most extreme cases of child obesity. Full Story | |
Millions at risk of cholera in Ethiopia: WHO Fri,15 Jul 2011 01:38 PM PDT Reuters - GENEVA (Reuters) - Five million people are at risk of cholera in drought-hitEthiopia, where acute watery diarrhea has broken out in crowded, unsanitary conditions, the World Health Organization (WHO) said on Friday. Full Story | |
Most drugs for Parkinson's psychosis unproven Fri,15 Jul 2011 01:36 PM PDT Reuters - NEW YORK (Reuters Health) - Nearly every prescription written to treat Parkinson's psychosis -- a common psychiatric side effect of Parkinson's disease -- is for medications that have not been shown to improve the condition, a new study finds. Full Story | |
Patients worse off with more-experienced docs? Fri,15 Jul 2011 01:35 PM PDT Reuters - NEW YORK (Reuters Health) - In a study that flies in the face of common sense, sicker patients turned out to fare worse under the care of seasoned doctors than when newcomers to medicine looked after them. Full Story | |
Traffic court does not reduce crashes later on Fri,15 Jul 2011 01:33 PM PDT Reuters - NEW YORK (Reuters Health) - Drivers who choose to fight a speeding ticket in court, rather than pay a fine by mail, are more likely to be involved in a car crash later on, a new study of Maryland drivers shows. Full Story | |
Medicare Part D sees falling drug costs: study Fri,15 Jul 2011 01:32 PM PDT Reuters - WASHINGTON (Reuters) - Cheaper generic drugs will continue to hold down costs for the U.S. government, insurers and patients enrolled in the federal prescription drug benefit, according to a report released on Friday. Full Story | |
|
|
Panel backs stricter blood cancer drug label Thu,14 Jul 2011 03:12 PM PDT Reuters - SILVER SPRING, Maryland (Reuters) - A U.S. advisory panel backed an experimental drug from Seattle Genetics Inc for treating two rare types of blood cancer, but recommended stricter labeling than the company sought. Full Story | |
U.S. medical devices spending steady: report Thu,14 Jul 2011 02:44 PM PDT Reuters - WASHINGTON (Reuters) - Medical devices accounted for about 6 percent of the total U.S. health spending in 2009, barely changed from 10 years earlier and slightly higher than two decades ago, according to an industry report. Full Story | |
Vitamin A may not prevent asthma: study Thu,14 Jul 2011 02:43 PM PDT Reuters - NEW YORK (Reuters Health) - Despite the important role of vitamin A in lung development, researchers have found that giving the nutrient to pregnant women or preschoolers in Nepal doesn't protect kids against asthma. Full Story | |
Black men survive longer in prison than out: study Thu,14 Jul 2011 02:42 PM PDT Reuters - NEW YORK (Reuters Health) - Black men are half as likely to die at any given time if they're in prison than if they aren't, suggests a new study of North Carolina inmates.Full Story | |
FDA panel backs Seattle Genetics drug for lymphoma Thu,14 Jul 2011 12:57 PM PDT Reuters - SILVER SPRING, Maryland (Reuters) - An experimental drug from Seattle Genetics Inc garnered unanimous backing from U.S. advisers for a second type of blood cancer. Full Story | |
EU customs seize $1.4 billion of fake goods in 2010 Thu,14 Jul 2011 11:53 AM PDT Reuters - BRUSSELS (Reuters) - Customs officials seized fake goods worth more than one billion euros ($1.4 billion) at European borders last year as they paid more attention to shipments ordered online, the European Commission said in a report on Thursday. Full |
No comments:
Post a Comment
No adult content please.
Articles accepted having references.
No advertisement accepted.